LL3733-4
[NEI] International classification for extraocular
Active
Basic Properties
- OID
- 1.3.6.1.4.1.12009.10.1.2371
- Name
- [NEI] International classification for extraocular
- Description
- Answers: 6; Scale: Ord; Code: -; Score: 1-4 This staging system is based on how much cancer remains after surgery to remove the tumor and whether the cancer has spread.
- LOINCs using this list
- 2
Answer List
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Stage 0 | 0 | LA4323-7 | |
| Stage I Stage I means that eye has already been removed and there is some microscopic spread to the optic nerve. These patients need adjuvant chemotherapy after surgery. |
1 | LA3664-5 | |
| Stage II Stage II means that the tumor has spread to the optic nerve or the sclera, which is the white part of the eye. Patients with this stage need adjuvant chemotherapy and possibly radiation therapy. |
2 | LA3661-1 | |
| Stage III means that the cancer has spread to the lymph nodes or the bony cavity that surrounds the eyeball. It is divided into two substages called stage IIIa and stage IIIb, depending on where the tumor has spread. The treatment for this stage involves both chemotherapy and radiation therapy. |
3 | LA3657-9 | |
| Stage IV In stage IV, the tumor has spread to distant areas of the body outside the eye, via the lymphatic system and blood vessels. Stage IV is divided into substages of IVa and IVb. Stage IVb is further divided into IVb1, IVb2, and IVb3, depending on the location of the spread. This stage of extraocular retinoblastoma is treated with high-dose chemotherapy followed by stem cell rescue. |
4 | LA3651-2 | |
| UnknownCopyright http://snomed.info/sct ID:261665006 Unknown (qualifier value) | UNK | LA4489-6 |
LOINC terms using this Answer List
| 79748-0 | Reese-Ellsworth Extraocular retinoblastoma classification at final disease stage Left eye |
| 79747-2 | Reese-Ellsworth Extraocular retinoblastoma classification at final disease stage Right eye |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LL3733-4 - ValueSet definition
- https:
//fhir.loinc.org/ValueSet/?url=http: //loinc.org/vs/LL3733-4 - ValueSet expansion
- https:
//fhir.loinc.org/ValueSet/$expand?url=http: //loinc.org/vs/LL3733-4
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright